Pentoxifylline for Acute Alcoholic Hepatitis (AAH)
Status:
Terminated
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to demonstrate the effectiveness of pentoxifylline compared to
placebo in AAH while studying putative mechanisms that are plausible and testable. The main
hypothesis is that pentoxifylline reduces the 90-day mortality of AAH.